141 related articles for article (PubMed ID: 31571250)
1. Case of metastatic extramammary Paget's disease treated with trastuzumab-biosimilar monotherapy after S-1 and docetaxel combination chemotherapy.
Kimura T; Akamatsu Y; Kajihara I; Fukushima S; Ihn H
J Dermatol; 2020 Jan; 47(1):e1-e2. PubMed ID: 31571250
[No Abstract] [Full Text] [Related]
2. S-1 in combination with docetaxel as salvage therapy for patients with metastatic extramammary Paget's disease.
Fukuda K; Hirai I; Nakamura Y; Fusumae T; Tanese K; Yaguchi T; Kawakami Y; Funakoshi T
Eur J Dermatol; 2020 Jun; 30(3):301-302. PubMed ID: 32540820
[No Abstract] [Full Text] [Related]
3. Successful treatment of metastatic extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.
Matsushita S; Yonekura K; Mera K; Kawai K; Kanekura T
J Dermatol; 2011 Oct; 38(10):996-8. PubMed ID: 21972953
[No Abstract] [Full Text] [Related]
4. Achieved good response of S-1 and docetaxel combination chemotherapy in two patients with metastatic extramammary Paget's disease.
Egashira S; Kajihara I; Kanemaru H; Uemura-Kiyohara M; Yamada-Kanazawa S; Nakahara S; Nagamoto E; Fukushima S; Jinnin M; Inoue Y; Ihn H
J Dermatol; 2017 May; 44(5):e103-e104. PubMed ID: 27882581
[No Abstract] [Full Text] [Related]
5. Weekly docetaxel monotherapy for metastatic extramammary Paget's disease: Retrospective single-institute analysis.
Nakamura Y; Tanese K; Hirai I; Fukuda K; Kawakami Y; Amagai M; Funakoshi T
J Dermatol; 2020 Apr; 47(4):418-422. PubMed ID: 32020662
[TBL] [Abstract][Full Text] [Related]
6. Successful TS-1 monotherapy as the second-line treatment for advanced extramammary Paget's disease: A report of two cases.
Kato J; Hida T; Yamashita T; Kamiya S; Horimoto K; Sato S; Takahashi H; Sawada M; Yamada M; Uhara H
J Dermatol; 2018 Jan; 45(1):80-82. PubMed ID: 28891079
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.
Kawakita R; Fusumae T; Oda S; Takeuchi A; Takasugi A; Yoshida T
J Dermatol; 2018 Sep; 45(9):e252-e253. PubMed ID: 29572930
[No Abstract] [Full Text] [Related]
8. S-1 induced a durable response in metastatic extramammary Paget's disease.
Mikoshiba Y; Uhara H; Kubo H; Okuyama R
J Dermatol; 2013 Aug; 40(8):664-5. PubMed ID: 23682853
[No Abstract] [Full Text] [Related]
9. Successful treatment of bilateral multiple lymph node metastases in extramammary Paget's disease with surgery and sequential chemotherapy of S-1 and docetaxel.
Ogata D; Hokama Y; Tsuchida T
J Dermatol; 2015 Dec; 42(12):1193-4. PubMed ID: 26331378
[No Abstract] [Full Text] [Related]
10. Combination chemotherapy with S-1 and docetaxel for cutaneous angiosarcoma resistant to paclitaxel.
Kajihara I; Kanemaru H; Miyake T; Aoi J; Masuguchi S; Fukushima S; Jinnin M; Ihn H
Drug Discov Ther; 2015 Feb; 9(1):75-7. PubMed ID: 25788055
[TBL] [Abstract][Full Text] [Related]
11. Single-agent taxane is useful in palliative chemotherapy for advanced extramammary Paget disease: a case series.
Kato M; Yoshino K; Maeda T; Nagai K; Oaku S; Hiura A; Fujisawa Y
Br J Dermatol; 2019 Oct; 181(4):831-832. PubMed ID: 30920650
[No Abstract] [Full Text] [Related]
12. Metastatic extramammary Paget's disease treated with paclitaxel and trastuzumab combination chemotherapy.
Takahagi S; Noda H; Kamegashira A; Madokoro N; Hori I; Shindo H; Mihara S; Hide M
J Dermatol; 2009 Aug; 36(8):457-61. PubMed ID: 19691751
[TBL] [Abstract][Full Text] [Related]
13. Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget's disease.
Watanabe S; Takeda M; Takahama T; Iwasa T; Tsurutani J; Tanizaki J; Shimizu T; Sakai K; Wada Y; Isogai N; Nishio K; Nakagawa K
Invest New Drugs; 2016 Jun; 34(3):394-6. PubMed ID: 26856856
[TBL] [Abstract][Full Text] [Related]
14. Monitoring serum cytokeratin 19 fragment 21-1 to determine the efficacy of docetaxel chemotherapy in advanced extramammary Paget's disease.
Onishi M; Maeda F; Akasaka T; Amano H
J Dermatol; 2019 Mar; 46(3):e83-e84. PubMed ID: 30194782
[No Abstract] [Full Text] [Related]
15. Docetaxel induced durable response in advanced extramammary Paget's disease: a case report.
Oguchi S; Kaneko M; Uhara H; Saida T
J Dermatol; 2002 Jan; 29(1):33-7. PubMed ID: 11837572
[TBL] [Abstract][Full Text] [Related]
16. Sequential use with imiquimod and surgery in extramammary Paget's disease.
Toledo F; Silvestre JF; Cuesta L; Ballester I; Latorre N; Monteagudo A
Dermatol Ther; 2012; 25(1):82-5. PubMed ID: 22591501
[TBL] [Abstract][Full Text] [Related]
17. Double involvement of extramammary Paget's disease in the genitalia and axilla.
Inui S; Fukuhara S; Asada H; Tadokoro T; Yoshikawa K; Itami S
J Dermatol; 2000 Jun; 27(6):409-12. PubMed ID: 10920590
[TBL] [Abstract][Full Text] [Related]
18. Treatment of mammary and extramammary Paget's skin disease with topical imiquimod.
Mirer E; El Sayed F; Ammoury A; Lamant L; Messer L; Bazex J
J Dermatolog Treat; 2006; 17(3):167-71. PubMed ID: 16854759
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of metastatic extramammary Paget's disease with pemetrexed monotherapy systemically and 5-fluorouracil topically.
Chen K; Liang H; Peng J; Zheng Y
Indian J Dermatol Venereol Leprol; 2019; 85(1):56-59. PubMed ID: 29536970
[TBL] [Abstract][Full Text] [Related]
20. A case of metastatic extramammary Paget's disease that responded to combination chemotherapy.
Yamazaki N; Yamamoto A; Wada T; Ishikawa M; Moriya Y; Nakanishi Y
J Dermatol; 1999 May; 26(5):311-6. PubMed ID: 10380432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
